Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin’s Lymphoma
Condition(s):CancerLast Updated:February 28, 2018Completed
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:February 28, 2018Completed
Condition(s):LymphomaLast Updated:August 18, 2021Completed
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:October 19, 2023Active, not recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:January 25, 2023Completed
Condition(s):Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic LymphomaLast Updated:September 18, 2018Completed
Condition(s):Stage III Melanoma; Stage IV MelanomaLast Updated:October 6, 2015Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:December 3, 2015Completed
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:April 27, 2021Completed
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:February 2, 2024Recruiting
Condition(s):Leukaemia, Lymphocytic, ChronicLast Updated:June 25, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.